drug
Relpax
Marketedupdated 6mo agoby $VTRS Viatris Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
News(1)
- Viatris boosts pain drug portfolio with $1.7B buyout of PaciraThe deal hands Viatris two non-opioid pain treatments that booked nearly $700 million in 2025 but could soon lose patent protection. Viatris vowed to use its “intellectual property expertise” to su…biopharma_dive · 1mo ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that